期刊文献+

舒尼替尼治疗转移性肾细胞癌的疗效与不良反应及其相关性解析

下载PDF
导出
摘要 目的:探讨舒尼替尼治疗转移性肾细胞癌的疗效和不良反应及其相关性。方法:本次医学研究以我院2011年1月~2014年1月收治的100例转移性肾细胞癌患者为观察对象,随机将其分为对照组和实验组,对照组患者接受传统方法治疗,实验组患者接受舒尼替尼治疗,回顾分析两组临床治疗效果。结果:实验组临床治疗总有效率明显高于对照组,不良反应发生率明显低于对照组(P〈0.05)。结论:本次医学研究结果证实,转移性肾细胞癌患者接受舒尼替尼治疗,临床治疗效果较为理想,治疗的安全性较高,因而临床推广和应用价值较高。
作者 曾旺焕
出处 《北方药学》 2015年第8期131-132,共2页 Journal of North Pharmacy
  • 相关文献

参考文献5

二级参考文献42

  • 1Novick AC,Campbell SC.Treatment of metastatic renal cell carcinoma//Walsh PC.Campbelrs urology.8th ed.Philadelphia:W.B.Saunders,2002:2715-2719.
  • 2Motzer RJ,Hutaon TE,Tomczak P,et al.Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.N Engl J Med,2007,356:115-124.
  • 3Eisenhauer EA,Therasae P,Bogaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1).Eur J Cancer,2009,45:228-247.
  • 4Kapoor A,Gharajeh A,Sheikh A,et al.Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.Curr Oncol,2009,16(Suppl 1):S60-66.
  • 5Wood L.First-line therapy with sunitinib in advanced renal cell carcinoma:interpretation of the overall survival data from ASCO 2008.Curr Oncol,2009,16(Suppl 1):S24-26.
  • 6Van der Veldt AA,Meijerink MR,van den Eertwegh AJ,et al.Sunitinib for treatment of advanced renal cell cancer:primary tumor response.Clin Cancer Rea,2008,14:2431-2436.
  • 7Kontovinis LF,Papazisis KT,Touplikioti P,et al.Sunitinib treatment for patients with clear-cell metastatic renal cell carcinorna:clinical outcomes and plasma angiogenesis markers.BMC Cancer,2009,9:82.
  • 8Kollmannsberger C,Soulieres D,Wong R,et al.Sunitinib therapy for metastatic renal cell carcinoma:recommendations for management of aide effects.Can Urol Assoc J,2007,1(2 Suppl):S41-54.
  • 9Motzer RJ, Michaelson MD, Redman BG, et ai. Activity of SU 11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platetel derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol, 2006, 24:16- 24.
  • 10National Cancer Institute Common Terminology Criteria for adverse events Version 3. 0 http://ctep, cancer, gov/protocolDevelopment/electronic_applications/docs/ctcaev3, pdf.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部